Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Clinical trial NCT00307567 · COMPLETED

Trial details

NCT number: NCT00307567
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Hepatitis B Diphtheria Haemophilus Influenzae Type b Poliomyelitis

Start date: 2005-11-01
Enrollment: 689

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.